Inflammatory-Related Perinatal Factors Tied to Later Childhood Dysregulation
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 19, 2023 -- Maternal inflammation risk factors during pregnancy may be associated with later dysregulation in children, according to a study published online in the December issue of the Journal of the American Academy of Child & Adolescent Psychiatry.
Jean A. Frazier, M.D., from UMass Chan Medical School in Worcester, and colleagues examined the relationship between perinatal factors and emotional, cognitive, and behavioral dysregulation in youth. The analysis included 18 cohorts that had both Child Behavior Checklist data (4,595 youth 6 to 18 years) and information on perinatal exposures including maternal prenatal infections.
The researchers found that 13.4 percent of youth met criteria for the Child Behavior Checklist-Dysregulation Profile (CBCL-DP), with a greater effect among boys than girls (15.1 versus 11.5 percent). Compared with youth without CBCL-DP, more youth with CBCL-DP were born to mothers with prenatal infections (28 versus 35 percent). There were significant associations with dysregulation for having a first-degree relative with a psychiatric disorder and being born to a mother with lower educational attainment, who was obese, who had any prenatal infection, and/or who smoked tobacco during pregnancy.
"In this large study, a few modifiable maternal risk factors with established roles in inflammation (maternal lower education, obesity, prenatal infections, and smoking) were strongly associated with CBCL-DP and could be targets for interventions to improve behavioral outcomes of offspring,” the authors write.
Several authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Diet-Induced Inflammation Positively Tied to Marker of Heart Failure
THURSDAY, June 6, 2024 -- There is a positive correlation between diet-induced inflammation and a heart failure biomarker, according to a study published online June 5...
FDA Approves First Liquid, Nonstimulant ADHD Treatment, Onyda XR
MONDAY, June 3, 2024 -- The U.S. Food and Drug Administration has approved once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for...
Pharmacological Treatment of ADHD May Cut Some Forms of Criminality
WEDNESDAY, May 29, 2024 -- Pharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.